Enhabit, Inc. (EHAB)
| Market Cap | 706.91M +75.3% |
| Revenue (ttm) | 1.06B +3.2% |
| Net Income | -3.20M |
| EPS | -0.06 |
| Shares Out | 51.23M |
| PE Ratio | n/a |
| Forward PE | 19.44 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,382,540 |
| Open | 13.79 |
| Previous Close | 13.79 |
| Day's Range | 13.79 - 13.81 |
| 52-Week Range | 6.47 - 14.22 |
| Beta | 0.96 |
| Analysts | Hold |
| Price Target | 13.84 (+0.29%) |
| Earnings Date | May 7, 2026 |
About EHAB
Enhabit, Inc. provides home health and hospice services in the United States. The Home Health segment offers nursing care; physical, occupational, and speech therapy; medical and social work; and home health aide services. This segment also provides patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer’s ... [Read more]
Financial Performance
In 2025, Enhabit's revenue was $1.06 billion, an increase of 2.44% compared to the previous year's $1.03 billion. Losses were -$4.60 million, -97.06% less than in 2024.
Financial StatementsAnalyst Summary
According to 5 analysts, the average rating for EHAB stock is "Hold." The 12-month stock price target is $13.84, which is an increase of 0.29% from the latest price.
News
Enhabit Home Health & Hospice Announces New Chief Executive Officer
DALLAS--(BUSINESS WIRE)--Enhabit, Inc., a leading home health and hospice provider, today announced that Dale Clift has been appointed president and CEO, following the successful completion of the com...
Enhabit Quarterly report: Q1 2026
Enhabit has published its Q1 2026 quarterly earnings report on May 7, 2026.
Enhabit Sets Stockholder Meeting Date of May 12, 2026, to Approve Transaction with Kinderhook
DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB) (“Enhabit” or the “Company”), a leading home health and hospice care provider, today announced that it will hold the special meeting of stockholders...
Enhabit Proxy statement: Proxy filing
Enhabit filed a proxy statement on April 14, 2026, providing details for shareholder voting and corporate governance matters.
Enhabit Proxy statement: Proxy filing
Enhabit filed a proxy statement on March 30, 2026, providing details for shareholder voting and corporate governance matters.
Enhabit downgraded to Hold from Buy at TD Cowen
TD Cowen downgraded Enhabit (EHAB) to Hold from Buy with a $13.80 price target following the company’s agreement to be acquired by Kinderhook Industries in an all-cash transaction valued at…
Enhabit Proxy statement: Proxy Filing
Enhabit filed a proxy statement on March 5, 2026, providing details for shareholder voting and corporate governance matters.
Enhabit reports Q4 EPS 14c, consensus 14c
Reports Q4 revenue $270.4M, consensus $270.6M. “Our fourth quarter 2025 results capped a pivotal year for Enhabit (EHAB), delivering an emerging growth story with year over year increases in patient…
Enhabit Reports Fourth Quarter 2025 Financial Results
DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the fourth quarter ended Dec. 31, 2025. “Our fourth q...
Enhabit Annual report: Q4 2025
Enhabit has published its Q4 2025 annual report on March 4, 2026.
Enhabit Earnings release: Q4 2025
Enhabit released its Q4 2025 earnings on March 4, 2026, summarizing the period's financial results.
Enhabit Slides: Q4 2025
Enhabit has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on March 4, 2026.
Enhabit Proxy statement: Proxy Filing
Enhabit filed a proxy statement on February 26, 2026, providing details for shareholder voting and corporate governance matters.
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Enhabit, Inc. (EHAB)
Bala Cynwyd, Pennsylvania--(Newsfile Corp. - February 24, 2026) - Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Enhabit, Inc. ("En...
Enhabit downgraded to Neutral from Buy at UBS
UBS analyst AJ Rice downgraded Enhabit (EHAB) to Neutral from Buy with a $13.80 price target following the company’s agreement to be acquired by Kinderhook Industries in an all-cash transaction…
Enhabit downgraded to Hold from Buy at Jefferies
Jefferies downgraded Enhabit (EHAB) to Hold from Buy with a price target of $13.80, up from $12.50, following the company’s agreement to be acquired by Kinderhook Industries in an all-cash…
Enhabit price target raised to $13.80 from $9.50 at Leerink
Leerink raised the firm’s price target on Enhabit (EHAB) to $13.80 from $9.50 and keeps a Market Perform rating on the shares after the company agreed to be acquired at…
Enhabit price target raised to $13.80 from $10.50 at Truist
Truist raised the firm’s price target on Enhabit (EHAB) to $13.80 from $10.50 and keeps a Hold rating on the shares. This morning, Enhabit announced the company has entered into…
Enhabit downgraded to Perform from Outperform at Oppenheimer
Oppenheimer analyst Michael Wiederhorn downgraded Enhabit (EHAB) to Perform from Outperform after the company agreed to be acquired by Kinderhook Industries in a transaction with a total enterprise va...
Enhabit to be acquired by Kinderhook Industries for $13.80 per share in cash
Enhabit (EHAB) announced it has entered into a definitive agreement to be acquired by Kinderhook Industries in an all-cash transaction for a total enterprise value of approximately $1.1B. Under the…
Enhabit to be Acquired by Kinderhook Industries
DALLAS & NEW YORK--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced it has entered into a definitive agreement to be acquired by Kinder...
Enhabit Proxy statement: Proxy Filing
Enhabit filed a proxy statement on February 23, 2026, providing details for shareholder voting and corporate governance matters.
Enhabit Proxy statement: Proxy Filing
Enhabit filed a proxy statement on February 23, 2026, providing details for shareholder voting and corporate governance matters.
Enhabit Proxy statement: Proxy Filing
Enhabit filed a proxy statement on February 23, 2026, providing details for shareholder voting and corporate governance matters.
Enhabit Home Health & Hospice Announces Date of 2025 Fourth Quarter Earnings Call
DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced it will report its financial results for the fourth quarter and fiscal year en...